Sample | Title | Value | Rank |
GSM958322 | U87-EV human glioblastoma xenograft - Control - 1 [HG-U133_Plus_2] | 4.62705 | 62 |
GSM958323 | U87-EV human glioblastoma xenograft - Control - 2 [HG-U133_Plus_2] | 4.51044 | 62 |
GSM958324 | U87-EV human glioblastoma xenograft - Control - 3 [HG-U133_Plus_2] | 4.47914 | 62 |
GSM958328 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 1 [HG-U133_Plus_2] | 4.49974 | 61 |
GSM958329 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 2 [HG-U133_Plus_2] | 4.51485 | 62 |
GSM958330 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 3 [HG-U133_Plus_2] | 5.32266 | 65 |
GSM958325 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 1 [HG-U133_Plus_2] | 4.64403 | 62 |
GSM958326 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 2 [HG-U133_Plus_2] | 4.51607 | 62 |
GSM958327 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 3 [HG-U133_Plus_2] | 4.51607 | 62 |